Kolexia
Vanacker Helene Oncologie médicale
Vanacker Helene
Oncologie médicale
Centre Léon-Bérard
Lyon, France
66 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du sein Tumeurs de l'ovaire Tumeurs des tissus mous Carcinome épithélial de l'ovaire Tumeurs des cordons sexuels et du stroma gonadique Sarcome du stroma endométrial Tumeurs de l'utérus Morsures et piqûres

Collaborateurs

Voir plus
Brahmi Mehdi
Brahmi Mehdi
Centre Léon-Bérard, Lyon, France
Dufresne Armelle
Dufresne Armelle
Centre Léon-Bérard, Lyon, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Cassier Philippe
Cassier Philippe
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Sandoz
2 collaboration(s)
Dernière en 2022
MSD
1 collaboration(s)
Dernière en 2022
Novartis
1 collaboration(s)
Dernière en 2020
Pfizer
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Patients' selection and trial matching in early-phase oncology clinical trials.
Critical reviews in oncology/hematology   23 février 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
British journal of cancer   05 janvier 2024
AMPHISARC: A Multicenter, Phase I/II Study Evaluating the Clinical Impact of HDM201 + Pazopanib in Patients With P53 Wild-type Advanced/ Metastatic Soft Tissue Sarcomas (AMPHISARC)
Essai Clinique (Centre Léon-Bérard)   06 décembre 2023
Oncology research congress: The essentials of the fifth International Symposium 2022 of the Cancer Research Center of Lyon.
Bulletin du cancer   06 octobre 2023
1921MO Patterns of care, outcome and molecular landscape of PATZ1-rearranged sarcomas identifies two prognostic profiles: A cohort study from the French Sarcoma Group (FSG)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1975P Systemic therapy for KIT/PDGFRA wild-type GIST
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
703P Prognostic scores for immunotherapy-based phase one trials (P1T): To GRIm or not to GRIm?
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
RAR-Immune: A Randomised, Comparative, Prospective, Multicentre Study of the Efficacy of Nivolumab + Ipilimumab Versus Pazopanib Alone in Patients With Metastatic or Unresectable Advanced Sarcoma of Rare Subtype (RAR-Immune)
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases.
JCO precision oncology   15 août 2023
PALPHA-1: Assessment of the Reasons for Accepting or Refusing Early Palliative Care by the Patients Included in an Early Phase Clinical Trial
Essai Clinique (Centre Léon-Bérard)   12 juillet 2023